SODIUM ACETATE — all Canadian products
10 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SODIUM ACETATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02181746 | SODIUM ACETATE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | Intravenous | SODIUM ACETATE 328 MG | Marketed | |
| 02139529 | SODIUM ACETATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intravenous | SODIUM ACETATE 328 MG | Marketed | |
| 02247204 | 16.4% SODIUM ACETATE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | SODIUM ACETATE 16.4 % | Cancelled Post Market | |
| 02366533 | CITRASATE C0125 | CHIEF MEDICAL SUPPLIES LTD | Solution | Haemodialysis | SODIUM ACETATE 1.11 G; SODIUM CHLORIDE 263 G; CALCIUM CHLORIDE 6.24 G; MAGNESIUM CHLORIDE 2.14 G; DEXTROSE 49.50 G; CITRIC ACID 6.91 G | Dormant | |
| 02373807 | H.E.L.P. ACETATE BUFFER PH 4.85 | B. BRAUN AVITUM AG | Solution | Haemodialysis | SODIUM ACETATE 27.22 G; ACETIC ACID 6.82 G | Dormant | |
| 01963910 | HYPERLYTE (MULTI-ELECTROLYTE CONCENTRATE) | B. BRAUN MEDICAL INC | Liquid | Intravenous | SODIUM ACETATE 2.72 G; POTASSIUM CHLORIDE 2.46 G; SODIUM GLUCONATE 1.09 G; MAGNESIUM ACETATE 860 MG; POTASSIUM ACETATE 690 MG; CALCIUM ACETATE 440 MG | Cancelled Post Market | |
| 02139618 | LYPHOLYTE | PHARMACEUTICAL PARTNERS OF CANADA INC | Solution | Intravenous | SODIUM ACETATE 2.7 G; POTASSIUM CHLORIDE 2.5 G; SODIUM GLUCONATE 1.1 G; MAGNESIUM ACETATE 860 MG; POTASSIUM ACETATE 690 MG; CALCIUM ACETATE 440 MG | Cancelled Post Market | |
| 01944940 | LYPHOLYTE MULTI-ELECTROLYTE CONC INJ | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | Liquid | Intravenous | SODIUM ACETATE 135 MG; POTASSIUM CHLORIDE 125 MG; SODIUM GLUCONATE 55 MG; MAGNESIUM ACETATE 43 MG; POTASSIUM ACETATE 34.5 MG; CALCIUM ACETATE 22 MG | Cancelled Post Market | |
| 00780642 | SODIUM ACETATE INJ 328MG/ML USP | SABEX INC | Liquid | Intravenous | SODIUM ACETATE 328 MG | Cancelled Post Market | |
| 01944843 | SODIUM ACETATE INJ 328MG/ML USP | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | Liquid | Intravenous | SODIUM ACETATE 328 MG | Cancelled Post Market |
Browse other molecules: